Nanoparticles loaded with neurotrophic factors, and preparation and applications thereof
A technology of neurotrophic factors and nano-microspheres, which can be applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, and nervous system diseases, etc., and can solve problems such as easy degradation, short half-life, and poor self-aggregation and absorption , to achieve the effects of good biocompatibility, extended half-life, and strong factor release function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0014] Example 1: Preparation of ε-polylysine-heparin nanospheres
[0015] Add 1 mL of ε-polylysine (3 mg / mL) aqueous solution to 2 mL of heparin (3 mg / mL) aqueous solution with stirring at room temperature and stir for 1 h. Then, 2.3 mg of genipin, a biocompatible cross-linking agent, was added to carry out the cross-linking reaction for 12 hours. After the reaction is completed, an aqueous ε-polylysine-heparin nanosphere dispersion is formed. The particle size range of the nano microsphere is 180-350nm.
Embodiment 2
[0016] Example 2: Preparation of ε-polylysine-heparin nanospheres loaded with nerve growth factor (NGF)
[0017] Add 1 mL of ε-polylysine (3 mg / mL) aqueous solution containing 1 μg nerve growth factor (NGF) to 2 mL of heparin (3 mg / mL) aqueous solution and stir for 1 h at room temperature. Then, 2.3 mg of genipin, a biocompatible cross-linking agent, was added to carry out the cross-linking reaction for 12 hours. After the reaction is completed, the epsilon-polylysine-heparin nanometer microsphere dispersion liquid loaded with neurotrophic factors is formed. The particle size range of the nano microsphere is 180-350nm. The added amount of nerve growth factor matches the amount required for treatment, the same below.
Embodiment 3
[0018] Example 3: Preparation of ε-polylysine-heparin nanospheres loaded with basic fibroblast growth factor (bFGF)
[0019] Add 1 mL of ε-polylysine (3 mg / mL) aqueous solution containing 1 μg of basic fibroblast growth factor (bFGF) to 2 mL of heparin (3 mg / mL) aqueous solution with stirring at room temperature and stir for 1 h. Then, 2.3 mg of genipin, a biocompatible cross-linking agent, was added to carry out the cross-linking reaction for 12 hours. After the reaction is completed, a neurotrophic factor-loaded ε-polylysine-heparin nanosphere dispersion is formed. The particle size range of the nano microsphere is 180-350nm.
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com